A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
West China Hospital
West China Hospital
Wake Forest University Health Sciences
University of California, San Diego
Institut Claudius Regaud
West China Hospital
West China Hospital
CNAO National Center of Oncological Hadrontherapy
Brooklyn ImmunoTherapeutics, LLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences